Aquallence Analysis
Aquallence, founded in 2010 in Israel, aims to revolutionize water disinfection and purification technologies on a global scale. The company's primary focus is on improving residential, municipal, and rural Point of Entry (POE) water disinfection and purification solutions.
The company's vision is to be a leading provider of "Water Shield" purification and disinfection technologies, ensuring safe water access worldwide. Aquallence utilizes ozone technology and extremely low energy to deliver high-quality water purification solutions.
Aquallence's flagship product, NanoBlue, stands as the world's first POE Plug & Play grid power-free solution for full household and residential water purification and disinfection. This system effectively removes virus, bacteria, cyst, arsenic 3 & 5, lead, mercury, iron, chlorine, and odors, setting a new standard in the market.
Furthermore, the company offers portable water purifying systems such as PortoBlue and EcoBlue, catering to mobile forces, rescue units, and special missions, particularly in disaster-stricken areas. Additionally, the CommuBlue system addresses water challenges in rural areas and urban centers with aging water infrastructure, aiming to combat sewage and waste contamination.
Aquallence's commitment to making the world a better place through improved water quality presents opportunities for potential investors who align with their vision for change.
There is no investment information
No recent news or press coverage available for Aquallence.
We care about your data, and we'd love to use cookies make your experience better.